Topotecan (Hycamptin) and Topotecan-Containing Regimens in the Treatment of Hematologic Malignancies-Reference-Cited by-同舟云学术

Topotecan (Hycamptin) and Topotecan-Containing Regimens in the Treatment of Hematologic Malignancies

Published:2006-01-25 Issue:1 Volume:922 Page:247-259
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

BERAN MILOSLAV,KANTARJIAN HAGOP M.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.2000.tb07043.x/fullpdf

Reference44 articles.

1. An early phase Ii study of CPT-11;Ohno;A new derivative of camptothecin for the treatment of leukemia and lymphoma. J. Clin. Oncol.,1990

2. Phase I study of topotecan, a new topoisomerase I inhibitor in patients with refractory or relapsed acute leukemia;Kantarjian;Blood,1993

3. Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia;Rowinsky;J. Clin. Oncol.,1994

4. A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia;Rowinsky;Clin. Cancer Res.,1996

5. In vitro and in vivo activity of topotecan against human 8-lineage acute lymphoblastic leukemia cells;Uckum;Blood,1995

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug design based on the carbon/silicon switch strategy;Russian Chemical Bulletin;2015-06

2. Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493);Leukemia & Lymphoma;2012-01-11

3. Chronic Myelomonocytic Leukemia (CMML);Chronic Myeloid Neoplasias and Clonal Overlap Syndromes;2010

4. Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia;Cancer Chemotherapy and Pharmacology;2005-07-12

5. Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening;Journal of Immunological Methods;2004-09